Related Experiment Video

Updated: Apr 25, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

2.6K

Limiting the power of p53 through the ubiquitin proteasome pathway

Vinod Pant1, Guillermina Lozano2

  • 1Department of Genetics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

Genes & Development
|August 17, 2014
PubMed

Insights

The ubiquitin proteasome pathway controls the p53 tumor suppressor. Regulators of p53, like ligases and deubiquitinating enzymes, are key to preventing cancer and have therapeutic potential.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The ubiquitin proteasome pathway (UPP) is essential for regulating protein stability and function.
  • The p53 tumor suppressor is a critical mediator of cellular responses to stress, including cell cycle arrest, senescence, and apoptosis.
  • Dysregulation of p53 activity is frequently observed in various cancers.

Purpose of the Study:

  • To review the physiological roles of ubiquitin ligases and deubiquitinating enzymes in controlling p53 levels and activity.
  • To discuss the impact of these regulators on tumor suppression and tumor-prone phenotypes.
  • To explore the therapeutic implications of targeting the p53 regulatory network.

Main Methods:

  • This review synthesizes existing literature on the UPP and its role in p53 regulation.
  • Key E3/E4 ligases and deubiquitinating enzymes that target p53 are identified and discussed.
  • The consequences of altered p53 regulation on cellular fate and tumorigenesis are examined.

Main Results:

  • E3 and E4 ligases, along with deubiquitinating enzymes, are crucial for modulating p53 stability and function.
  • Aberrant regulation of p53 by these enzymes can lead to either uncontrolled cell proliferation or tumor suppression.
  • Understanding these regulatory mechanisms provides insights into cancer development.

Conclusions:

  • The ubiquitin proteasome pathway plays a pivotal role in maintaining p53 homeostasis.
  • Targeting p53 regulators offers promising therapeutic strategies for cancer treatment.
  • Further research into these pathways can uncover novel avenues for cancer intervention.
Keywords:
Mdm2mouse modelsp53 regulationubiquitination

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

8.9K
In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity09:45

In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity

Published on: January 29, 2018

8.8K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
7.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
6.5K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
8.5K